Release Date: 2024-06-10

Interventional Radiological Treatments in Thyroid Malignancies

Mesut Ozgokce (Author)

Release Date: 2024-06-10

Thyroid nodules are commonly found due to the widespread use of ultrasonography, with a prevalence of 19-67%. The diagnosis of thyroid cancer has tripled over the past 30 years. Most thyroid nodules are benign, with only 7-15% being malignant. Various guidelines like TI-RADS and ATA have been developed to improve the diagnosis and determine which [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inThe Radiology of Cancer
    First Page507
    Last Page517
    DOIhttps://doi.org/10.69860/nobel.9786053359364.32
    Page Count11
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    Thyroid nodules are commonly found due to the widespread use of ultrasonography, with a prevalence of 19-67%. The diagnosis of thyroid cancer has tripled over the past 30 years. Most thyroid nodules are benign, with only 7-15% being malignant. Various guidelines like TI-RADS and ATA have been developed to improve the diagnosis and determine which nodules should be biopsied, though none are highly sensitive or specific. The standard treatment for thyroid nodules is total thyroidectomy and radioactive iodine therapy, which can lead to complications such as nerve injury, parathyroid gland damage, scars, hypothyroidism, and requires prolonged hospitalization under general anesthesia. These drawbacks have led to the popularity of minimally invasive treatments, such as chemical (ethanol injection) and thermal ablation (radiofrequency, microwave, laser ablation, and high- intensity focused ultrasound). Minimally invasive treatments are effective for benign nodules and show promise for local tumor control in malignant nodules. Thermal ablation is also used for other conditions like parathyroid adenoma and small thyroid cancers. While surgery remains the primary option for recurrent thyroid cancers, ablation offers an alternative for patients with severe fibrosis or those who cannot tolerate surgery. This approach avoids risks associated with traditional surgery, such as vocal cord paralysis, hypothyroidism, hypoparathyroidism, scarring, long- term hormone therapy, and complications from anesthesia.

    Mesut Ozgokce (Author)
    Professor, Van Yuzuncu Yil University
    https://orcid.org/0000-0002-3095-2446
    3He completed primary and high school education in Van. He studied at Kocaeli University Medical School. Later, he did radiology residency at Atatürk University. He completed his mandatory service as a radiology specialist at Van Training and Research Hospital for two years. Afterwards, he worked at a private hospital for one year. Since 2016, he has been working in the Radiology Department at Van Yüzüncü Yıl University, specializing in both cardiothoracic imaging and interventional radiology. He received associate professorship in 2018 and has been serving as a professor since June 2024. He has published numerous scientific articles and given oral presentations at both national and international conferences. For English language training, he spent some time in Dublin (Ireland). Later, He worked as an observer in interventional radiology at UPM University (Malaysia) and Rush University (Chicago). Additionally, he is a member of the Turkish Society of Interventional Radiology, the Turkish Radiology Society, and the Turkish Thoracic Radiology Society.

    • Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009; 39: 699-706

    • Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014; 140: 317-22

    • Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-71

    • Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid 2009; 19: 1363-72]

    • Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2017; 317: 1888903.

    • US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2017; 317: 1882-7

    • Galanti MR, Ekbom A, Grimelius L, Yuen J, et al. Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 1997; 75: 451-6

    • Levine RA. Current guidelines for the management of thyroid nodules. Endocr Pract 2012;18:596–9. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004;28:271–6

    • Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 2008;18:1244–50.

    • Ji L, Wu Q, Gu J, Deng X, Zhou W, Fan X, et al. Ultrasound-Guided Percutaneous Laser Ablation for Papillary Thyroid Microcarcinoma: A Retrospective Analysis of 37 Patients. Cancer Imaging (2019) 19:16. doi: 10.1186/s40644-019-0204-x

    • Biamonte E, Solbiati L, Ierace T, Colombo P, Lavezzi E, Mazziotti G, et al. Medullary Thyroid Carcinoma Treated With Percutaneous UltrasoundGuided Radiofrequency Ablation. Endocrine (2019) 65:515–9. doi: 10.1007/ s12020-019-01995-w

    • Cesareo R, Palermo A, Benvenuto D, Cella E, Pasqualini V, Bernardi S, et al. Efficacy of Radiofrequency Ablation in Autonomous Functioning Thyroid Nodules. A Systematic Review and Meta-Analysis. Rev Endocr Metab Disord (2019) 20:37–44. doi: 10.1007/s11154-019-09487-y

    • Livraghi T, et al. Treatment of autonomous thyroid nodules with percutaneus ethanol injection: preliminary results. Work in progress. Radiology. 1990 Jun;175(3):827-9.

    • Bennedbaek FN, Nielsen LK, Hegedüs L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab. 1998 Mar; 83(3):830-5.

    • Lippi F, et al. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group. J Clin Endocrinol Metab. 1996 Sep;81(9):3261-4.

    • Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol 2013;23:1044-1049

    • Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 2009;19:219225

    • Zhang L, Zhou W, Zhan W, Peng Y, Jiang S, Xu S. Percutaneous Laser Ablation of Unifocal Papillary Thyroid Microcarcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Assessing Local Therapeutic Response. World J Surg (2018) 42:2476–84. doi: 10.1007/ s00268-018-4500-6

    • Choi Y, Jung SL, Bae JS, Lee SH, Jung CK, Jang J, et al. Comparison of Efficacy and Complications Between Radiofrequency Ablation and Repeat Surgery in the Treatment of Locally Recurrent Thyroid Cancers: A SingleCenter Propensity Score Matching Study. Int J Hyperthermia (2019) 36:1:358–366. doi: 10.1080/02656736.2019.1571248

    • Jeong SY, Baek JH, Choi YJ, Chung SR, Sung TY, Kim WG, et al. Radiofrequency Ablation of Primary Thyroid Carcinoma: Efficacy According to the Types of Thyroid Carcinoma. Int J Hyperthermia (2018) 34:611–6. doi: 10.1080/02656736.2018.1427288

    • Tong MY, Li HS, Che Y. Recurrent Medullary Thyroid Carcinoma Treated With Percutaneous Ultrasound-Guided Radiofrequency Ablation: A Case Report. World J Clin Cases (2021) 9(4):864–70. doi: 10.12998/wjcc.v9.i4.864

    • Garberoglio R, Aliberti C, Appetecchia M, Attard M, Boccuzzi G, Boraso F, et al. Radiofrequency Ablation for Thyroid Nodules: Which Indications? first Ital Opin statement J Ultrasound (2015) 18:423–30. doi: 10.1007/s40477-015-0169-y

    • Oda H, Miyachi A, Ito Y, Yoshioka K, Nakayama A, Sasai H, et al. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery. Thyroid (2016) 26(1):150–5. doi: 10.1089/thy.2015.0313

    • Yan L, Lan Y, Xiao J, Lin L, Jiang B, Luo Y. Long-Term Outcomes of Radiofrequency Ablation for Unifocal Low-Risk Papillary Thyroid Microcarcinoma: A Large Cohort Study of 414 Patients. Eur Radiol (2021) 31(2):685–94. doi: 10.1007/s00330-020-07128-6

    • Wang LY, Nixon IJ, Palmer FL, Thomas D, Tuttle RM, Shaha A, et al. Comparable Outcomes for Patients With pT1a and pT1b Differentiated Thyroid Cancer: Is There a Need for Change in the AJCC Classification System? Surgery (2014) 156(6):1484–90. doi: 10.1016/j.surg.2014.08.037

    • Xiao J, Zhang Y, Zhang M, Lan Y, Yan L, Luo Y, et al. UltrasonographyGuided Radiofrequency Ablation vs. Surgery for the Treatment of Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Comparative Study. Clin Endocrinol (Oxf) (2021) 94(4):684–91. doi: 10.1111/cen.14361

    • Ha SM, Sung JY, Baek JH, Na DG, Kim JH, Yoo H, et al. Radiofrequency Ablation of Small Follicular Neoplasms: Initial Clinical Outcomes. Int J Hyperthermia (2017) 33(8):931–7. doi: 10.1080/02656736.2017.1331268

    • Wu W, Gong X, Zhou Q, Chen X, Chen X, Shi B. US-guided percutaneous microwave ablation for the treatment of benign thyroid nodules. Endocr J. 2017;64(11):1079–1085. doi:10.1507/endocrj.EJ17-0152

    • Klein JA, Lee Jr FT, Hinshaw L, Lubner MG, Brace CL. Overview of thermal ablation devices: Microwave. In: Clark T, Sabharwal T, eds. Interventional Radiology Techniques in Ablation. London, UK: Springer; 2013:21–28. doi:10.1007/978-0-85729-094-6

    • Zheng BW, Wang JF, Ju JX, Wu T, Tong G, Ren J. Efficacy and safety of cooled and uncooled microwave ablation for the treatment of benign thyroid nodules: a systematic review and meta-analysis. Endocrine. 2018 Nov;62(2):307–17

    • iu YJ, Qian LX, Liu D, Zhao JF. Ultrasoundguided microwave ablation in the treatment of benign thyroid nodules in 435 patients. Exp Biol Med (Maywood). 2017 Sep;242(15): 1515–23.

    • Zhi X, Zhao N, Liu Y, Liu JB, Teng C, Qian L. Microwave ablation compared to thyroidectomy to treat benign thyroid nodules. Int J Hyperthermia. 2018 Aug;34(5):644–52.

    • Yan J, Qiu T, Lu J, Wu Y, Yang Y. Microwave ablation induces a lower systemic stress response in patients than open surgery for treatment of benign thyroid nodules. Int J Hyperthermia. 2018 Aug;34(5):606–10.

    • Mauri G, Sconfienza LM. Percutaneous ablation holds the potential to substitute for surgery as first choice treatment for symptomatic benign thyroid nodules. Int J Hyperthermia. 2017 May;33(3):301–2

    • Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid: Off J Am Thyroid Assoc (2010) 20(11):1253–61. doi: 10.1089/ thy.2010.0189

    • Korkusuz H, Sennert M, Fehre N, Happel C, Grünwald F. Local thyroid tissue ablation by high-intensity focused ultrasound: effects on thyroid function and first human feasibility study with hot and cold thyroid nodules. Int J Hyperthermia. 2014 Nov;30(7):480–5.

    • Lang BH, Wu AL. High intensity focused ultrasound (HIFU) ablation of benign thyroid nodules a systematic review. J Ther Ultrasound. 2017 May;5(1):11

    • Trimboli P, Pelloni F, Bini F, Marinozzi F, Giovanella L. High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results. Endocrine. 2019 Aug;65(2):312–7

    • Trimboli P, Castellana M, Sconfienza LM, Virili C, Pescatori LC, Cesareo R, Giorgino F, Negro R, Giovanella L, Mauri G. Efficacy of thermal ablation in benign nonfunctioning solid thyroid nodule: A systematic review and meta-analysis. Endocrine 2020;67:35-43.

    • Yilmaz S, Habibi HA, Yildiz A, Altunbas H. Thyroid Embolization for Nonsurgical Treatment of Nodular Goiter: A Single-Center Experience in 56 Consecutive Patients. J Vasc Interv Radiol 2021;32:1449-56

    • Heck K, Happel C, Grünwald F, Korkusuz H. Percutaneous Microwave Ablation of Thyroid Nodules: Effects on Thyroid Function and Antibodies. Int J Hyperthermia (2015) 31(5):560–7. doi: 10.3109/02656736.2015.1032371

    • Deandrea M, Garino F, Alberto M, Garberoglio R, Rossetto R, Bonelli N, et al. Radiofrequency Ablation for Benign Thyroid Nodules According to Different Ultrasound Features: An Italian Multicentre Prospective Study. Eur J Endocrinol (2019) 180:79–87. doi: 10.1530/EJE-18-0685

    • Bae DS, Woo JW, Paek SH, Kwon H, Chai YJ, Kim SJ, et al. Antiadhesive Effect and Safety of Sodium Hyaluronate-Carboxymethyl Cellulose Membrane in Thyroid Surgery. J Korean Surg Soc (2013) 85(5):199– 204. doi: 10.4174/jkss.2013.85.5.199

    • Ha SM, Shin JY, Baek JH, Song DE, Chung SR, Choi YJ, et al. Does Radiofrequency Ablation Induce Neoplastic Changes in Benign Thyroid Nodules: A Preliminary Study? Endocrinol Metab (2019) 34:169–78. doi: 10.3803/EnM.2019.34.2.169

    • Rabuffi P, Spada A, Bosco D, Bruni A, Vagnarelli S, Ambrogi C, et al. Treatment of Thyroid Nodules With Radiofrequency: A 1−Year Follow−Up Experience. J Ultrasound (2019) 22:193–9. doi: 10.1007/s40477019-00375-4

    • Tong, M., Li, S., Li, Y., Li, Y., Feng, Y., & Che, Y. (2019). Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. International journal of hyperthermia, 36(1), 1277-1285.

    Share This Chapter!